Price $7.77 |
Market Cap
4.04B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
20.0
|
P/B
4.18
|
P/S
8.99
|
Dividend %
-
|
|
P/CF
9.2
|
P/FCF
19.8
|
Op. Cash Flow
262.6K
|
FCF
0.7
|
|
Op. Margin
63.90%
|
Net Margin
47.40%
|
ROE
22.70%
|
ROI
13.60%
|
|
ROA
18.90%
|
EPS Growth
-
|
Current Ratio
7.9
|
Debt/Equity
0.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AcelRx Pharmaceuticals Inc (ACRX) | $0.42 | - | - | 67.1M | Strong Buy |
| Acura Pharmaceuticals, Inc. (ACUR) | $0.48 | - | - | 32.8M | Strong Buy |
| Agenus Inc (AGEN) | $2.49 | - | - | 865.5M | Strong Buy |
| Akumin Inc (AKU) | $1.40 | - | - | 184.9M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $20.46 | - | - | 1.09B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
